Dr. Capon obtained a BSc in biological sciences (1992) and PhD in medical genetics (1999) from La Sapienza, University of Rome, Italy.  Her interest in the genetics of psoriasis brought her to the United Kingdom. She first moved to the University of Leicester as a Wellcome Trust Traveling Research Fellow (2001), then took on a Lectureship in human molecular genetics at University College London (2004). She joined King’s College London in 2006 as a lecturer, was promoted to senior lecturer in 2014, and to reader (associate professor) in 2018. Her main research interest is the genetic basis of psoriasis. In recent years, the Capon lab has been concentrating on two main research lines: the identification of disease genes in pustular forms of psoriasis and the role of interleukin-36 in the pathogenesis of pustular and plaque psoriasis. This research has been published in high-impact journals including the American Journal of Human Genetics, the Journal of Allergy and Clinical Immunology, and Science Translational Medicine.

Last Updated: Oct 09, 2018

Dr. Johann Gudjonsson, MD, PhD is a graduate of the University of Iceland Medical School. He completed his internship and dermatology residency training at the University of Michigan. In 2008, Dr. Gudjonsson joined the faculty of the University of Michigan Department of Dermatology. Dr. Gudjonsson sees general dermatology patients at the University of Michigan Taubman Center and directs the inpatient consultation service. Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. Dr. Gudjonsson is the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. He received the Young Investigator Award from the American Academy of Dermatology in 2007 and his work has earned several research awards, including awards from the American Skin Association, the Dermatology Foundation, Doris Duke Foundation and the NIH.

Last Updated: Jan 08, 2020

Professor Bachelez is professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in immunology in 1999. Professor Bachelez’s clinical and scientific research focuses on immunogenetics of inflammatory skin diseases at the Institut National de la Santé et de la Recherche Médicale (INSERM) at the Imagine Institute in Necker Hospital. His areas of scientific interest include molecular mechanisms of psoriasis and psoriasis-related diseases, and other immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is a board member of the International Psoriasis Council, and general secretary-Treasurer-elect of the European Society for Dermatological Research (ESDR). Professor Bachelez has published more than 230 manuscripts in peer-reviewed journals, including the New England Journal of Medicine , The Lancet , Journal of Clinical Investigation , and Arthritis and Rheumatism as leading author.

Last Updated: Jul 01, 2019

Jörg C. Prinz is Full Professor of Dermatology and Venereology and Deputy Chair of the Clinic for Dermatology and Allergology of the Ludwig-Maximilian University (LMU) in Munich, Germany. Beyond his commitments in patient care and teaching at medical school his main research interest is in the analysis of the T-cell mediated immunopathogenesis of psoriasis and the identification of the target cells and autoantigens of psoriatic the pathogenic psoriatic immune response; he is also interested in developing novel therapies for T-cell mediated autoimmune disorders, and has been actively involved in preparing evidence-based guidelines for psoriasis treatment. He has published extensively in major peer-reviewed journals.

Last Updated: May 08, 2019

Dr. Menter is Chairman of the Division of Dermatology and Director of the Dermatology Residency program for Baylor Scott & White, and Clinical Professor of Dermatology at the University of Texas Southwestern Medical School, both in Dallas. After obtaining his medical degree from the University of Witwatersrand in Johannesburg, South Africa, Professor Menter completed his residency in dermatology at the University of Pretoria in South Africa and thereafter fellowships at Guy's Hospital in London and St. John's Hospital for Diseases of the Skin in London, as well as the University of Texas Southwestern Medical School. Dr. Menter is board-certified in dermatology. He is involved in multiple clinical, investigative and drug research studies, predominantly those relating to psoriasis. He currently has published 418 articles in major Dermatology and Medical Journals, in addition to 4 books and 6 chapters, as well as discovering the 1st gene for Psoriasis published in the journal “ Science ” in 1994 with Professor Anne Bowcock. In 1968, Dr. Menter represented the South Africa Rugby team, the Springboks, against France. In August 2004, he founded the International Psoriasis Council (IPC).

Last Updated: Feb 10, 2020

Dr. Mrowietz is the Editor-in-Chief of the Archives of Dermatological Research, and a member of the Executive Board of the German Dermatological Association, as well as a member of the Scientific Advisory Board of the German Psoriasis Association. He is also a member of numerous national and international dermatological societies. Prof. Mrowietz' main scientific and clinical interests are psoriasis and psoriasis therapy, wound healing and pathological scarring. He has 118 published articles referenced in the Medline data base, and has written numerous chapters in textbooks incl. Fitzpatrick's Dermatology in General Medicin and Braun-Falco's Dermatologie und Venerology. Furthermore, Dr. Mrowietz has written four books in German about psoriasis (for patients and physicians), immunosuppressive therapy and cyclosporin in dermatology. Prof. Mrowietz has been awarded the Oscar-Gans-F_rderpreis in 1993 and the Presi den wissenschaftlichen Nachwuchs der orddeutschen Hautk

Last Updated: Apr 05, 2017

Professor Schmitt-Egenolf is professor of dermatology at Umeå University. He studied medicine in Frankfurt, Vienna, and Edmonton, and began his psoriasis research with a thesis on the immunogenetics of psoriasis under the guidance of Enno Christophers and Wolfram Sterry. Thereafter, he completed his specialist training at the Charité in Berlin. He was appointed associate professor of dermatology at the Norwegian University of Science and Technology in Trondheim, Norway, in 2000. Since 2002, he has been working at Umeå University, where he was appointed head of the division of dermatovenereology in 2012 and full professor and distinguished teacher in 2014. His main research interests are melanoma and genodermatoses RWE (real-world evidence) in psoriasis. Marcus founded the Swedish national psoriasis registry PsoReg in 2006 and co-founded the international PsoNet register. He has published numerous peer-reviewed articles about psoriasis as well as several book chapters. He serves on the editorial boards of three medical journals and is an associate editor for the British Journal of Dermatology. Professor Schmitt-Egenolf is the dermatologist responsible for the national psoriasis guidelines from the Swedish Board of Health and Welfare and serves as senior adviser for several public agencies and organizations, including the Swedish psoriasis patient organization.

Last Updated: Oct 09, 2018

Tiago Torres is Professor of Dermatology at the Abel Salazar Institute of Biomedical Sciences, University of Porto. He received his medical degree from the Faculty of Medicine, University of Porto, completed a residency program in Dermatology and Venereology at Centro Hospitalar do Porto and finished his PhD thesis in 2014 studying the role of psoriasis-associated systemic inflammation in atherosclerosis. Currently, he is the Head of the Psoriasis Unit and Clinical Trials Unit of the Department of Dermatology of Centro Hospitalar do Porto. Tiago Torres has been involved in the development of national guidelines for the treatment of psoriasis, has won the “Juvenal Esteves” Prize from the Portuguese Society of Dermatology and Venereology with research projects in psoriasis and psoriatic arthritis in 2011, 2013, 2017 and 2018 and is the present President of the Portuguese Group of Psoriasis. He serves as Associate Editor of Acta Médica Portuguesa, Journal of the Portuguese Society of Dermatology and Venereology and Drugs in Context and belongs to the editorial board of Drugs and the Foundation René Touraine’s Book “Therapeutics In Dermatology” and has been the editor of the Portuguese book “Psoriasis and Psoriatic Arthritis”. His main research topics in dermatology are immunodermatology, immunology and immunopharmacology of psoriasis and atopic dermatitis.

Last Updated: Jun 26, 2020

Professor Lambert is professor and academic chair of the dermatology department at Ghent University. She obtained her dermatology training at the university and her PhD in medical sciences in melanosome transport, awarded with the Roche Fundamental Research Award. Research stays were performed at Boston University, United States; Leiden Center for Electron Microscopy, the Netherlands; the dermatology department at Hôpital E Herriot, Lyon, France; and St John’s Dermatology Department, London, United Kingdom. Professor Lambert is president of the Royal Belgian Society of Dermatology and Venereology and a board member of the Royal Academy of Medicine, Belgium, and the Fondation René Touraine (FRT). She also serves as president of the Skin Inflammation and Psoriasis International (SPIN) Network of FRT, belongs to several advisory boards in psoriasis, and is a member of the European Dermatology Forum. Since 2014, she has been an editorial assistant for the Journal of Investigative Dermatology in the field of psoriasis and human skin pigmentation. Her interests include improving management of immune-mediated inflammatory skin disorders through an evidencebased, integrated research approach.

Last Updated: Oct 09, 2018

Dr. April Armstrong is Associate Dean at Keck School of Medicine of the University of Southern California (USC). She also serves as Director of Clinical Research Support at the Southern California Clinical and Translational Science Institute (CTSI). Dr. Armstrong also serves as Vice Chair and Director of Psoriasis Program in the dermatology department at USC. Dr. Armstrong obtained her MD and completed dermatology residency at Harvard. She also obtained a MPH in Clinical Effectiveness from Harvard School of Public Health. Dr. Armstrong is highly committed to clinical research and the care of patients with inflammatory skin diseases such as psoriasis and atopic dermatitis. Her research in focuses on (1) investigating comorbidities related to psoriasis and atopic dermatitis, (2) identifying treatment patterns, treatment goals, and economic burden of inflammatory skin disease, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. She has conducted over 100 clinical trials and published over 210 articles in scientific journals. She holds multiple leadership positions at professional societies, including the National Psoriasis Foundation, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council, and the American Academy of Dermatology. She is an associate Editor for JAMA Dermatology and has also served on the editorial boards of JAAD and Telemedicine and eHealth.

Last Updated: Jul 31, 2019

Luigi Naldi took a diploma in Classical Studies and a Degree in Industrial Design at Scuola Politecnica di Design in Milan before moving to Medicine. He graduated as a medical doctor at the University of Pavia in 1981. From 1984 to 1986 he was a junior investigator at the Laboratory of Clinical Pharmacology of the Mario Negri Institute in Milan. In 1988 he moved to the clinical arena (Dermatology) at the Department of Dermatology of the University of Milan, Bergamo General Hospital. He always considered the clinical setting as the natural laboratory for clinical research. Since 1986 he is coordinating a collaborative research group in Italy, the Italian Group for Epidemiologic Research in Dermatology (GISED). He is a co-founder of the European Dermatoepidemiology Network (EDEN). In 2003, he established a research center at the Bergamo General Hospital, Centro Studi GISED, with the aim of promoting integrated clinical research programs in Dermatology.

Last Updated: Apr 05, 2017

Prof. Lluís Puig is Director of the Dermatology Department at Hospital de la Santa Creu i Sant Pau (HSCSP) in Barcelona and Prof. of Dermatology at Autonomous University of Barcelona (UAB) Medical School. Prof. Puig received a medical degree (Hon) at the Medical Faculty of UAB and was a recipient of the Special Curricular Award upon graduating in 1982. In 1987 he completed his residency training in Dermatology at HSCSP Department of Dermatology and received the Spanish Board Certificate in Medical-Surgical Dermatology and Venereology. In 1991 he completed his PhD on pharmacologic modulation of lipid inflammatory mediators in psoriasis at UAB, and was recipient to the Special Award for doctoral theses during that year. Prof. Puig worked as a Senior Research Associate at the Institute of Biomedical Research. His body of work includes nine research projects, on a wide variety of subjects related to the pathophysiology of psoriasis, experimental pharmacology and inmunohistopathology, among others. Over the past ten years, Prof. Puig has focused his clinical research on treatment of psoriasis with biological agents and has participated in 21 clinical trials to date. The results of his research have been presented at both national and international meetings, have been the subject of more than 250 papers, including review articles and continuous medical education papers, and 10 international book chapters. Prof. Puig is an Editorial Board Member of Piel, Actas Dermosifiliogrficas, Medicina Cutnea Latinoamericana, Medicina Clnica, among other journals. He served as a reviewer for a wide number of scientific publications including the Archives of Dermatology, the British Journal of Dermatology and the Journal of the European Academy of Dermatology and is a founding member of several working groups of the Spanish Academy of Dermatology and Venereology. He is a member of the EADV, AAD, ESDR, ASDP, ISDP, GRAPPA, and other societies. He is a board member of the International Psoriasis Council.

Last Updated: Jan 26, 2018

Dr. Mrowietz is the Editor-in-Chief of the Archives of Dermatological Research, and a member of the Executive Board of the German Dermatological Association, as well as a member of the Scientific Advisory Board of the German Psoriasis Association. He is also a member of numerous national and international dermatological societies. Prof. Mrowietz' main scientific and clinical interests are psoriasis and psoriasis therapy, wound healing and pathological scarring. He has 118 published articles referenced in the Medline data base, and has written numerous chapters in textbooks incl. Fitzpatrick's Dermatology in General Medicin and Braun-Falco's Dermatologie und Venerology. Furthermore, Dr. Mrowietz has written four books in German about psoriasis (for patients and physicians), immunosuppressive therapy and cyclosporin in dermatology. Prof. Mrowietz has been awarded the Oscar-Gans-F_rderpreis in 1993 and the Presi den wissenschaftlichen Nachwuchs der orddeutschen Hautk

Last Updated: Apr 05, 2017